Insulin Pumps Market Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast Report To 2016 GlobalData's Medical Devices sector report, "Insulin Pumps - Medical Devices Pipeline Assessment, 2016" provides an overview of Insulin Pumps currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Pumps pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Insulin Pumps under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects For further information on this report, please visit http://www.radiantinsights.com/research/insulin-pumps-medical-devices-pipelineassessment-2016 - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons to Buy The report enables you to - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage - Identify and understand important and diverse types of Insulin Pumps under development - Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date. Table Of Content: Table of Contents 2 1.1 List of Tables 5 1.2 List of Figures 7 2 Introduction 8 2.1 Insulin Pumps Overview 8 3 Products under Development 9 3.1 Insulin Pumps - Pipeline Products by Stage of Development 9 3.2 Insulin Pumps - Pipeline Products by Segment 10 3.3 Insulin Pumps - Pipeline Products by Territory 11 3.4 Insulin Pumps - Pipeline Products by Regulatory Path 12 3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date 13 3.6 Insulin Pumps - Ongoing Clinical Trials 14 Get Sample Copy of Report Here: http://www.radiantinsights.com/research/insulin-pumpsmedical-devices-pipeline-assessment-2016#tabs-4 4 Insulin Pumps - Pipeline Products under Development by Companies 15 4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development 15 4.2 Insulin Pumps - Pipeline Products by Stage of Development 16 5 Insulin Pumps Companies and Product Overview 17 5.1 Amrita Vishwa Vidyapeetham Company Overview 17 5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17 5.2 Andain, Inc Company Overview 19 5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 19 5.3 Cellnovo Ltd. Company Overview 21 5.3.1 Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21 5.4 CeQur SA Company Overview 25 5.4.1 CeQur SA Pipeline Products & Ongoing Clinical Trials Overview 25 5.5 ConvaTec Healthcare B S.a.r.l. Company Overview 27 5.5.1 ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 27 5.6 Debiotech S.A. Company Overview 28 5.6.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 28 5.7 Hospira, Inc. Company Overview 31 5.7.1 Hospira, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 5.8 Insulet Corporation Company Overview 33
5.8.1 Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview 33 5.9 InsuLine Medical Ltd. Company Overview 36 5.9.1 InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36 5.10 LifeScan, Inc. Company Overview 40 5.10.1 LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40 5.11 MedSolve Technologies, Inc. Company Overview 42 5.11.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42 5.12 Medtronic plc Company Overview 43 5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43 5.13 MicroPort Scientific Corporation Company Overview 47 5.13.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 47 5.14 NanoMed Ltd Company Overview 50 5.14.1 NanoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 50 5.15 Phluid Corporation Company Overview 51 5.15.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 51 5.16 Sensile Medical AG Company Overview 52 5.16.1 Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 52 5.17 SFC Fluidics LLC Company Overview 55 5.17.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 55 5.18 Spring Health Solutions Ltd. Company Overview 56 5.18.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56 5.19 Tandem Diabetes Care, Inc. Company Overview 57 5.19.1 Tandem Diabetes Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57 5.20 ViCentra B.V. Company Overview 59 5.20.1 ViCentra B.V. Pipeline Products & Ongoing Clinical Trials Overview 59 5.21 Ypsomed Holding AG Company Overview 60 5.21.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 60 Read More Reports on Medical Devices Markets: http://www.radiantinsights.com/catalog/medical-devices 6 Insulin Pumps- Recent Developments 63 6.1 Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results 63 6.2 Apr 28, 2016: Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates 2016 Guidance 65 6.3 Apr 13, 2016: New Data Shows Benefits of Medtronic Insulin Pumps for People with Type 2 Diabetes 66 6.4 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 67 6.5 Mar 17, 2016: Medtronic Proposes Proxy Access 67 6.6 Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement 67 6.7 Mar 14, 2016: Tandem Diabetes Care Announces Appointment of Dr. Henry Anhalt as Board Member 67
6.8 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 68 6.9 Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results 69 6.10 Feb 25, 2016: Insulet Enters into Licensing Agreement with Mode AGC 72 6.11 Feb 24, 2016: Ypsomed expands the distribution of mylife OmniPod in Europe 73 6.12 Feb 24, 2016: Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results 73 6.13 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 74 6.14 Feb 02, 2016: Tandem Diabetes Care Expands Commercial Leadership 74 6.15 Jan 29, 2016: Liberty Medical to Acquire Neighborhood Diabetes from Insulet for USD5 Million 75 6.16 Jan 11, 2016: FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System For Use in Children 75 6.17 Jan 11, 2016: Medtronic and Chengdu Sign Insulin Pump Manufacturing Agreement 76 6.18 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 76 6.19 Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance 77 For Further Inquiries: http://www.radiantinsights.com/research/insulin-pumps-medicaldevices-pipeline-assessment-2016 6.20 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved 77 6.21 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 78 6.22 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference 78 6.23 Nov 26, 2015: Two Subsidiaries of MicroPort Recognized as One of Shanghai's the First Group of High-tech Enterprise 80 6.24 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79 80 6.25 Nov 17, 2015: Tandem Diabetes Care Announces Retirement of Board Chairman Lonnie Smith; Dick Allen Appointed as Successor Chairman 80 6.26 Oct 29, 2015: Tandem Diabetes Care Reports Third Quarter 2015 Financial Results 81 6.27 Oct 29, 2015: Greatbatch Reports 2015 Third Quarter Results 82 6.28 Oct 13, 2015: Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 84 6.29 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments 85 6.30 Sep 09, 2015: MicroPort Scientific Corporation Announce Leadership Changes in MicroPort Orthopedics Subsidiary and Membership Changes in CEC, IEC 85
About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com